NCT02899000 - A Treatment for Severe Inflammatory Acne Subjects | Biotech Hunter

Enrollment

186

Participants

Timeline

Start Date

July 29, 2016

Primary Completion Date

March 28, 2017

Study Completion Date

June 27, 2017

Conditions

Acne Vulgaris

Interventions

DRUG

Adapalene 0.3% / benzoyl peroxide 2.5% emulsion gel

Topical acne therapy

DRUG

Oral doxycycline hyclate

Tetracycline-class oral antibacterial 200 mg daily (2 tablets \[50 mg\], twice daily)

Trial Locations (1)

Galderma Laboratories, LP, Fort Worth